SL

Sonam Lakhotia

Director Director DIN 10497978
DIN 10497978 First appointment Feb 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2024
Shareholding value Locked Premium profile

About Sonam Lakhotia

Sonam Lakhotia has 2 years in corporate governance. Formerly with 1 company, such as Sympa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10497978
Primary Designation Director
First Appointment 08 Feb 2024
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sympa Pharma Private Limited U21001MP2023PTC067439
Director 08 Feb 2024 2023 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sympa Pharma Private Limited
Premium access

Shareholding and investment profile for Sonam Lakhotia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonam Lakhotia

Sonam Lakhotia has 2 years in corporate governance. Formerly with 1 company, such as Sympa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sonam Lakhotia is associated with 0 companies as a director.

Sonam Lakhotia has expertise in General Business.

Sonam Lakhotia has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available